Sodium-glucose co-transporter-2 inhibitors in heart failure and chronic kidney disease: the role of empagliflozin
In the case of chronic kidney disease (CKD) development in patients with cardiovascular diseases (CVD), heart failure (HF) is more ...
M. Batushin